, Cancer Journal

M. Hunault-berger, M Carré 7 , M-A Couturier 8 , E Daguindau 9 , J-P Marolleau 10 , F Orsini-Piocelle 11, J Delaunay LM Fornecker, vol.1, issue.25 1 21

. Maladies-du-sang, . Chu-angers, . Crcina, and . Inserm,

C. Service-d-'hématologie and . Poitiers,

C. Service-d-'hématologie and . Reims,

H. Clinique, C. , and I. Universitaire-du-cancer-toulouse-oncopole,

C. Service-d-'hématologie and . Boulogne,

C. Service-d-'hématologie and . Nancy,

. Service-d-'hématologie,

. Institut-d-'hématologie and . De-cancérologie, Hôpital Augustin Morvan

C. Service-d-'hématologie, C. Besançonhématologie, and . Amiens,

C. Service-d-'hématologie and . Annecy,

C. Service-d-'hématologie and . Nantes,

. Service-d-'hématologie,

C. Service-d-'hématologie-et-thérapie-cellulaire, . Tours, C. France, C. Mulhouse, and . Perpignan, , p.17

. Service-d-'hématologie,

. Service-d-'hématologie and . Ch-côte-basque,

C. Département-d-'hématologie-et-d-'oncologie and . Hautepierre,

H. Clinique and H. Pontchaillou, Hématologie Clinique, vol.21, issue.22

S. Hématologie and H. Lapeyronie, , p.24

H. Biologique and C. Iuc-toulouse-oncopole,

C. 25-hématologie-biologique and . De, Nantes, vol.1035

B. Lowenberg, G. Ossenkoppele, W. Van-putten, H. Schouten, C. Graux et al., High-Dose Daunorubicin in Older Patients with Acute Myeloid Leukemia, New England Journal of Medicine, vol.361, issue.13, pp.1235-1248, 2009.
DOI : 10.1056/NEJMoa0901409

A. Pigneux, J. Harousseau, F. Witz, M. Sauvezie, M. Bene et al., Addition of Lomustine to Idarubicin and Cytarabine Improves the Outcome of Elderly Patients With De Novo Acute Myeloid Leukemia: A Report From the GOELAMS, Journal of Clinical Oncology, vol.28, issue.18, pp.3028-3034, 2010.
DOI : 10.1200/JCO.2009.26.4648

URL : https://hal.archives-ouvertes.fr/hal-00849638

U. Platzbecker and U. Germing, Combination of Azacitidine and Lenalidomide in Myelodysplastic Syndromes or acute Myeloid Leukemia???a wise Liaison?, Leukemia, vol.118, issue.9, pp.1813-1819, 2013.
DOI : 10.1056/NEJMoa1013343

U. Platzbecker, F. Braulke, A. Kundgen, K. Gotze, G. Bug et al., Sequential combination of azacitidine and lenalidomide in del(5q) higher-risk myelodysplastic syndromes or acute myeloid leukemia: a phase I study, Leukemia, vol.29, issue.6, pp.1403-1407, 2013.
DOI : 10.1200/JCO.2010.31.8576

M. Sekeres, R. Tiu, R. Komrokji, J. Lancet, A. Advani et al., Phase 2 study of the lenalidomide and azacitidine combination in patients with higher-risk myelodysplastic syndromes, Blood, vol.120, issue.25, pp.4945-4951, 2012.
DOI : 10.1182/blood-2012-06-434639

D. Pollyea, H. Kohrt, L. Gallegos, M. Figueroa, O. Abdel-wahab et al., Safety, efficacy and biological predictors of response to sequential azacitidine and lenalidomide for elderly patients with acute myeloid leukemia, Leukemia, vol.72, issue.5, pp.893-901, 2012.
DOI : 10.1046/j.0902-4441.2003.00184.x

G. Ramsingh, P. Westervelt, A. Cashen, G. Uy, K. Stockerl-goldstein et al., A phase 1 study of concomitant high-dose lenalidomide and 5-azacitidine induction in the treatment of AML, Leukemia, vol.27, issue.3, pp.725-728, 2013.
DOI : 10.1200/JCO.2004.99.116

D. Pollyea, J. Zehnder, S. Coutre, J. Gotlib, L. Gallegos et al., Sequential azacitidine plus lenalidomide combination for elderly patients with untreated acute myeloid leukemia, Haematologica, vol.98, issue.4, pp.591-596, 2013.
DOI : 10.3324/haematol.2012.076414

R. Narayan, J. Garcia, . Perciva-lm, C. Berube, S. Coutre et al., Sequential azacitidine plus lenalidomide in previously treated elderly patients with acute myeloid leukemia and higher risk myelodysplastic syndrome, Leukemia & Lymphoma, vol.94, issue.3, pp.1-7, 2015.
DOI : 10.1038/leu.2013.58

C. Dinardo, N. Daver, E. Jabbour, T. Kadia, G. Borthakur et al., Sequential azacitidine and lenalidomide in patients with high-risk myelodysplastic syndromes and acute myeloid leukaemia: a single-arm, phase 1/2 study, The Lancet Haematology, vol.2, issue.1, pp.12-20, 2015.
DOI : 10.1016/S2352-3026(14)00026-X

B. Tawfik, S. Sliesoraitis, S. Lyerly, H. Klepin, J. Lawrence et al., Efficacy of the hypomethylating agents as frontline, salvage, or consolidation therapy in adults with acute myeloid leukemia (AML), Annals of Hematology, vol.25, issue.5, pp.47-55, 2014.
DOI : 10.1038/leu.2011.9

Y. Boumber, H. Kantarjian, J. Jorgensen, S. Wen, S. Faderl et al., A randomized study of decitabine versus conventional care for maintenance therapy in patients with acute myeloid leukemia in complete remission, Leukemia, vol.26, issue.11, pp.2428-2431, 2014.
DOI : 10.1182/blood-2009-03-211003

W. Blum, B. Sanford, R. Klisovic, D. Deangelo, G. Uy et al., Maintenance therapy with decitabine in younger adults with acute myeloid leukemia in first remission: a phase 2 Cancer and Leukemia Group B Study (CALGB 10503), Leukemia, vol.3, issue.1, pp.34-39, 2017.
DOI : 10.1158/0008-5472.CAN-04-4532

A. Wei, P. Tan, S. Perruzza, C. Govindaraj, S. Fleming et al., Maintenance lenalidomide in combination with 5-azacitidine as post-remission therapy for acute myeloid leukaemia, British Journal of Haematology, vol.110, issue.2, pp.199-210, 2015.
DOI : 10.1002/cncr.23112

A. Pigneux, M. Bene, P. Guardiola, C. Recher, J. Hamel et al., Addition of Androgens Improves Survival in Elderly Patients With Acute Myeloid Leukemia: A GOELAMS Study, Journal of Clinical Oncology, vol.35, issue.4, pp.387-393, 2017.
DOI : 10.1200/JCO.2016.67.6213

URL : https://hal.archives-ouvertes.fr/hal-01529184

, International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license